• Barclays (BCS) upgraded Tesla (TSLA) to Overweight from Equal Weight, raising its price target to $450 from $370, implying roughly 21% upside from the $372.22 reference price.
  • The upgrade cites improving automotive fundamentals, accelerating robotaxi activity, strong energy-storage demand, and a possible Tesla–SpaceX (SPCX) combination as catalysts.
  • Tesla shares rose 1.9% in premarket trading, but the move remains a snapshot and not a closing return.

Barclays Turns Bullish

Tesla shares gained 1.9% in premarket trading Monday after Barclays upgraded the electric-vehicle maker to Overweight from Equal Weight and lifted its price target to $450 from $370. The target implies roughly 21% upside from the $372.22 reference price cited in the report—not from the subsequent premarket level.

The upgrade marks a sharp reversal from Barclays’ cautious stance just after Tesla’s October 21 earnings, when the bank was still questioning how the company would unlock growth and how to interpret its lower capital-spending plan. Now, Barclays sees a more constructive setup.

Catalysts and Caveats

Barclays points to four main drivers: improving automotive fundamentals, accelerating robotaxi activity, strong energy-storage demand, and a possible combination with SpaceX. The bank expects Tesla’s auto business to grow this year after two years of declines, with additional upside in 2027 from Full Self-Driving-related demand and Shanghai exports.

Tesla’s latest quarter showed improving automotive gross margins excluding regulatory credits—18.1%, up from 16.3% in Q2 and 15.4% a year earlier. However, operating expenses jumped 39% year over year as Tesla invested heavily in AI, robotics, and other projects, limiting how much of that margin improvement reached operating profit. Revenue was essentially flat at $28.046 billion, while operating income fell 56% to $718 million.

The robotaxi story has also evolved. Barclays describes an initially slow ramp followed by a recent acceleration in miles driven. Tesla says its Cybercab entered the Austin robotaxi fleet on September 3, 2026, and cumulative unsupervised miles increased eightfold quarter over quarter. Still, these are progress indicators, not proof of profitable large-scale deployment.

On energy, Tesla reported record storage orders and backlog, with management saying Megapack capacity is nearly sold out for 2027. Barclays sees potential for shipment growth above 50%. But energy generation and storage revenue fell 16% in the third quarter despite storage deployments rising 10% to 13.7 GWh, partly due to tariff-related customer refunds.

Merger Talk Remains Exploratory

Reports say Tesla and SpaceX have formed special committees to explore a combination, but neither company has announced a merger agreement. Barclays’ expectation of a premium for Tesla shareholders is its investment thesis—not an agreed transaction term. Telemetry analyst Sam Abuelsamid argues that consolidating Musk’s control may be an important motivation; that is his interpretation, not an established transaction rationale.

What to Watch

Investors will watch for further analyst revisions, details about the merger exploration, fourth-quarter vehicle demand, and additional robotaxi operating data. Tesla’s reduced capital-spending outlook—now approximately $20 billion for 2026, down from a previously indicated $25 billion-plus—supports near-term cash preservation, but analysts disagree over whether it reflects efficiency or slower investment execution.

The main counterargument to the bullish case is execution and valuation risk: Tesla must turn early deployment milestones into durable profits while operating expenses remain elevated. Morgan Stanley (MS) raised its target to $410 while retaining Equal Weight, and Canaccord (CF.TO) raised its target to $442 while keeping a Buy rating—showing that improving operating indicators have not produced agreement on valuation.

The most useful interpretation of the headline is a change in confidence about Tesla’s future earnings mix—not confirmation that its current profit weakness, autonomy risks, or merger uncertainty have been resolved.